Načítá se...
An ATRActive future for differentiation therapy in AML
The success of all-trans retinoic acid (ATRA) therapy in acute promeylocytic leukemia (APL) has spawned numerous attempts to translate the paradigm of differentiation therapy to non-APL acute myelocytic leukemia (AML). However, the results of clinical trials have been overall disappointing. In this...
Uloženo v:
| Vydáno v: | Blood Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494875/ https://ncbi.nlm.nih.gov/pubmed/25631637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2015.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|